Back to top

Tale of the Tape

Zacks Equity Research

Navidea Biopharmaceuticals (NAVB) Surges: Stock Moves 10.2% Higher
December 05, 2013


Trades from $3
Navidea Biopharmaceuticals, Inc. (NAVB - Snapshot Report) was a big mover last session, as the company saw its shares rise by over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 30% since Nov 20.

This medical appliances & equipment company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Navidea Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the medical instrument industry include Natus Medical Inc. (BABY - Snapshot Report), Cynosure, Inc. (CYNO - Snapshot Report) and CryoLife Inc. (CRY - Snapshot Report). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>